Bill Ackman supports Valeant Pharma (VRX) CEO Pearson - CNBC
(Updated - November 5, 2015 2:23 PM EST)
Bill Ackman supports Valeant Pharma (NYSE: VRX) CEO Mike Pearson, according to a letter seen by CNBC.
In a letter to Mr. Person, Ackman said, "In light of recent press reports, I though it would be helpful for me to communicate my thoughts on your leadership of Valeant. We share the board's confidence in you and your leadership."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Atlassian (TEAM) comes ahead of Street estimates in Q1 but shares tumble
- Boeing (BA) Cut To Baa3 From Baa2 By Moody's, Outlook Negative
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
Create E-mail Alert Related Categories
Hedge Funds, Management Changes, Short Sales, Trader TalkRelated Entities
William AckmanSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!